Latest News - ResMed
Top Corporates Hub
ResMed
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
19.09.2026 08:18
ResMed Inc. (NYSE:RMD) is well positioned to benefit from the long-term growth of the global obstructive sleep apnea (OSA) treatment market. Likewise, the company remains well positioned to benefit from growing awareness and penetration in the global market, backed by a robust product portfolio. The company’s OSA portfolio includes CPAP and APAP machines, led by […]
ResMed: A Significant Upside Despite The Perceived Risk
10.09.2026 07:18
ResMed has been de-rated from 30x to under 21x earnings despite 17% EPS growth, driven by narrative rather than fundamentals. See why RMD stock is a Buy.
Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer
01.09.2026 13:30
SEATTLE, September 01, 2026--Frazier Healthcare Partners ("Frazier"), a private equity firm focused exclusively on the healthcare industry, today announced the closing of its acquisition of MatrixCare (the "Company") from Resmed (NYSE & ASX: RMD).
2 Profitable Stocks Worth Investigating and 1 We Turn Down
01.09.2026 12:30
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Which S&P500 stocks are moving before the opening bell on Wednesday?
12.08.2026 12:35
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
Resmed’s stock falls by 7% on soft FY27 outlook
10.08.2026 11:08
Resmed highlighted that factors including suspended ventilator sales and ongoing macro uncertainty had contributed to its tempered FY27 outlook.
RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts
10.08.2026 05:33
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts’ consensus estimates.
ResMed Q4 Earnings Call Highlights
09.08.2026 04:03
ResMed (NYSE:RMD) reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electroni
ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...
07.08.2026 05:12
ResMed Inc (RMD) delivers 9% revenue growth and 16% EPS growth in Q4 FY2026, while navigating Astral-related challenges and guiding to 5-7% core growth for FY2027.
ResMed (RMD) Faces An Earnings Test After A Rebound That Still Looks Undervalued
06.08.2026 13:16
Why the upcoming ResMed earnings matter ResMed (RMD) is back in focus ahead of its forthcoming earnings report, with Wall Street projecting quarterly earnings of $2.90 per share and revenue of about $1.46b for the period. See our latest analysis for ResMed. ResMed shares have climbed in recent weeks, with a 7 day share price return of 4.55% and a 90 day share price return of 8.28%. However, the year to date share price return is still down 8.49%, and the 1 year total shareholder return has...
3 Large-Cap Stocks to Consider Right Now
31.07.2026 13:31
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
3 Cash-Heavy Stocks to Research Further
23.07.2026 07:24
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital.
ResMed Inc (NYSE:RMD) Offers a Quality Dividend Built on Strong Profitability and Financial Health
15.07.2026 12:50
Discover how the Best Dividend Stocks screen identifies sustainable payers like ResMed (RMD), combining high dividend ratings with strong profitability and health ratings for long-term stability.
2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore
14.07.2026 10:23
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
ResMed (RMD) Sells MatrixCare To Refocus On Sleep And Respiratory Health
10.07.2026 11:14
ResMed (NYSE:RMD) has agreed to divest its MatrixCare business to a private equity buyer. The deal centers on refocusing the company around its sleep and respiratory health technologies and connected care platform. The transaction reflects a move away from post acute care software toward ResMed's core medical device and digital health operations. For investors watching ResMed, the exit from MatrixCare marks a clear effort to tighten the company’s focus on sleep apnea, respiratory care...
Gapping S&P500 stocks in Wednesday's session
08.07.2026 14:35
Wednesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Resmed sharpens sleep care focus with $490m software business sale
08.07.2026 13:53
Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.
Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over'
08.07.2026 12:12
Oil prices spiked following an exchange of strikes between the US and Iran
Here is why Taiwan Semiconductor (TSM) Is Among the Best Stocks in Glen Kacher’s Portfolio
08.07.2026 12:00
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio. As of the quarter ended March 31, 2026, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) represents 14.40% of Glen Kacher’s Light Street Portfolio. Additionally, the fund holds a put option position valued at $36,904,140 in […]